The largest database of trusted experimental protocols

4 protocols using cd3 buv805

1

Multiparametric Flow Cytometry of tPCLS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single‐cell suspensions of tPCLS were generated as described above. Single‐cell suspensions were blocked with FcR blocking reagent (Miltenyi Biotec) in 0.5% PBS‐BSA for 20 min, stained with fluorochrome‐conjugated antibodies, and analyzed on a FACSSymphony A5SE flow cytometer (BD Biosciences). Live single cells were identified by FSC and SSC characteristics. The data were analyzed using FlowJo V10 (TreeStar). All antibodies and secondary reagents were titrated to determine optimal concentrations. Comp‐Beads (BD) were used for single‐color compensation to create multicolor compensation matrices. For gating, fluorescence minus one control was used. The instrument calibration was controlled daily using Cytometer Setup and Tracking Beads (BD Biosciences). The following antibodies were used: CD3‐BUV805 (#612896, BD Biosciences), CD4‐BB630 (#562316, BD Biosciences), CD8‐BV650 (#743067, BD Biosciences), CD14‐PerCP‐Cy5.5 (#561116, BD Biosciences), CD15‐BUV805 (#742057, BD Biosciences), CD16‐BV650 (#563692, BD Biosciences), CD19‐APC‐H7 (#560252, BD Biosciences), CD25‐PE‐Cy7 (#557741, BD Biosciences), CD33‐BV510 (#563257, BD Biosciences), CD45‐AF700 (#368514, BD Biosciences), CD80‐BV711 (#740801, BD Biosciences), CD206‐PE/Cy7 (#321124, BioLegend), CD326‐FITC (#324203, BioLegend), HLA‐DR‐APC/Fire750 (#307658, BioLegend), MerTK‐BV421 (#367603, BioLegend).
+ Open protocol
+ Expand
2

Multi-Dimensional Immune Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
For protein expression analysis following isolation cells were collected and stained with the following antibodies for surface protein expression: CD3 APC-Cy7 (BioLegend), CD4 AF-700 (BioLegend), CD8 PE-Cy7 (BioLegend), CD45RA BV-605 (BioLegend), CD27 AF-488 (BioLegend), CD8 BUV-496 (BD Biosciences), CD3 BUV-805 (BD Biosciences), CD4 BV-750 (BD Biosciences), CD45RA BUV-395 (BD Biosciences), and CCR7 BV-786 (BD Biosciences). Dead cells were excluded from the analysis by using Zombie-UV (Biolegend). Doublets and double-positive CD4/CD8 cells were removed through sequential gating. Flow cytometry acquisition was done using the BD LSRII with BD FACSDiva. Data was analyzed by FlowJo 10.1r7 and GraphPad Prism 9.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry of Human NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell suspensions were stained with combinations of the following fluorochrome-conjugated antibodies following established guidelines57 (link): CD56 PE/Dazzle 594 (1:200), CD137 PE/cyanine7 (1:50) and CD57 BV605 (1:25; all BioLegend); CD7 BV786 (1:25), CD56 BUV737 (1:50), CD3 BUV805 (1:50), streptavidin BUV395 (1:100), CD16 BUV496 (1:50) and CD337 (NKp30) BV421 (1:25; all BD Biosciences); CD159a (NKG2A) biotin/PE-Vio770 (both 1:50) and CD159c (NKG2C) PE (1:100; all REAfinity, Miltenyi Biotec); CD337 (NKp30) eFluor 450 (1:25), CD3 APC-eFluor 780 (1:50), CD14 APC-eFluor 780 (1:50) and CD19 APC-eFluor 780 (1:50; all Thermo Fisher) and anti-FcεRI, γ subunit-FITC (1:50; Merck). Dead cells were excluded using Fixable Viability Dye eFluor 780 (Thermo Fisher) or a Zombie Aqua Fixable Viability kit (BioLegend). Data were acquired on an LSR Fortessa (BD Biosciences). Cell sorting was performed on a FACSAria II (BD Biosciences). FlowJo v10 was used for analysis of flow cytometry data, and GraphPad Prism v8.4.3 was used for statistical analysis.
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry of Human NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell suspensions were stained with combinations of the following fluorochrome-conjugated antibodies following established guidelines57 (link): CD56 PE/Dazzle 594 (1:200), CD137 PE/cyanine7 (1:50) and CD57 BV605 (1:25; all BioLegend); CD7 BV786 (1:25), CD56 BUV737 (1:50), CD3 BUV805 (1:50), streptavidin BUV395 (1:100), CD16 BUV496 (1:50) and CD337 (NKp30) BV421 (1:25; all BD Biosciences); CD159a (NKG2A) biotin/PE-Vio770 (both 1:50) and CD159c (NKG2C) PE (1:100; all REAfinity, Miltenyi Biotec); CD337 (NKp30) eFluor 450 (1:25), CD3 APC-eFluor 780 (1:50), CD14 APC-eFluor 780 (1:50) and CD19 APC-eFluor 780 (1:50; all Thermo Fisher) and anti-FcεRI, γ subunit-FITC (1:50; Merck). Dead cells were excluded using Fixable Viability Dye eFluor 780 (Thermo Fisher) or a Zombie Aqua Fixable Viability kit (BioLegend). Data were acquired on an LSR Fortessa (BD Biosciences). Cell sorting was performed on a FACSAria II (BD Biosciences). FlowJo v10 was used for analysis of flow cytometry data, and GraphPad Prism v8.4.3 was used for statistical analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!